{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:40:03Z","timestamp":1742229603113,"version":"3.38.0"},"posted":{"date-parts":[[2025,1,8]]},"group-title":"In Review","reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,31]]},"abstract":"<title>Abstract<\/title>\n        <p>Lysophosphatidylinositol (LPI) is an endogenous signaling molecule for the GPR55 receptor. Previous studies have shown that arachidonoyl-lysophosphatidylinositol (LPI-20:4) produced an increase in the inflammatory mediators NLPR3 (inflammasome \u2212\u20093 marker) and IL-1b in neurons from both rat dorsal root ganglion (DRG) and hippocampal cultures. Because LPI is comprised of a family of lipid structures that vary in fatty acyl composition, the current work examined neuroinflammatory responses to various LPI structures in DRG and hippocampal cultures as assessed by high content fluorescent imaging. Major endogenous LPI fatty acyl structures consisting of 16:0, 18:0, 18:1 or 20:4 were compared for their effects on IL-1b, NLRP3 and GPR55 immunoreactive areas of neurites and cell bodies after a 6-hour treatment. Among these four LPI structures, only LPI-20:4 treatment produced increases in immunoreactive areas for GPR55, NLRP3 and IL-1b in DRG and hippocampal neurites. In contrast, all other LPI structures tested produced a decrease in all of these inflammatory immunoreactive areas in both neurites and cell bodies. Additional studies with LPI-20:4 treatment indicated that IL-6, IL-18 and TNF-a were significantly increased in neurites of DRG and hippocampal cultures. However, oleoyl-lysophosphatidylinositol (LPI-18:1) treatment produced decreases in these three cytokines. Using the viability dye alamar blue, LPI-20:4 was shown to produce concentration-dependent decreases, whereas all other endogenous LPI structures produced increases with this assay. These studies indicate that fatty acyl structure is the major determinant of LPI for neuroinflammatory responses in DRG and hippocampal cultures, with LPI-20:4 showing pro-inflammatory effects and all other endogenous LPIs tested exhibited anti-inflammatory responses.<\/p>","DOI":"10.21203\/rs.3.rs-5742954\/v1","type":"posted-content","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:45:46Z","timestamp":1736333146000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of Fatty Acyl Composition for Lysophosphatidylinositol on Neuroinflammatory Responses in Primary Neuronal Cultures"],"prefix":"10.21203","author":[{"given":"Douglas E.","family":"Brenneman","sequence":"first","affiliation":[{"name":"Kannalife Sciences, Inc Pennsylvania Biotechnology Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Petkanas","sequence":"additional","affiliation":[{"name":"Kannalife Sciences, Inc Pennsylvania Biotechnology Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ippolito","sequence":"additional","affiliation":[{"name":"Temple University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Jane","family":"Ward","sequence":"additional","affiliation":[{"name":"Temple University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"11665","DOI":"10.3390\/ijms222111665","article-title":"Targeting oxidative stress: novel coumarin-based inverse agonist of GPR55","volume":"22","author":"Apweiler M","year":"2021","unstructured":"Apweiler M, Saliba SW, Streyczek J, Hurrle T et al (2021) Targeting oxidative stress: novel coumarin-based inverse agonist of GPR55. Int J Mol Sci 22:11665. 10.3390\/ijms222111665","journal-title":"Int J Mol Sci"},{"year":"2024","author":"Apweiler M","key":"ref2","unstructured":"Apweiler M, Saliba SW, Sun L, Streyczek J, Normann C, Hellwig S, Brase S, Fiebich BL (2024) Modulation of neuroinflammation and oxidative stress by targeting GPR55 \u2013 new approaches in the treatment of psychiatric disorders. Mol Psych May 25 doi.org\/10\/1038\/s41380-024-02614-5"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Bih CI","year":"2015","unstructured":"Bih CI, Chen T, Nunn AVW, Bazelot M, Dallas M, Whalley BJ (2015) Molecular targets of cannabidiol in neurological disorders. Neurotherap 12:699\u2013730. doi.org\/10.1007\/s13311-015-0377-3","journal-title":"Neurotherap"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1021\/acsmedchemlett.8b00333\/+","article-title":"Discovery of 1,4-naphthoquinones as a new class of antiproliferative agents targeting GPR55","volume":"10","author":"Badolato M","year":"2019","unstructured":"Badolato M, Carullo G, Caroleo MC, Cione E, Aiello F, Manetti F (2019) Discovery of 1,4-naphthoquinones as a new class of antiproliferative agents targeting GPR55. ACS Med Chem Lett 10:402\u2013406. 10.1021\/acsmedchemlett.8b00333\/+","journal-title":"ACS Med Chem Lett"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12031-018-1154-7","article-title":"Pharmacological comparisons between cannabidiol and KLS-13019","volume":"66","author":"Brenneman DE","year":"2018","unstructured":"Brenneman DE, Petkanas D, Kinney (2018) Pharmacological comparisons between cannabidiol and KLS-13019. J Mol Neurosci 66:121\u2013134. 10.1007\/s12031-018-1154-7","journal-title":"J Mol Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12031-019-01321-z","article-title":"Knockdown siRNA targeting the mitochondrial sodium-channel WA exchanger-1 inhibits the protective effects of two cannabinoids against acute paclitaxel toxicity","volume":"68","author":"Brenneman DE","year":"2019","unstructured":"Brenneman DE, Kinney WA, Ward SJ (2019) Knockdown siRNA targeting the mitochondrial sodium-channel WA exchanger-1 inhibits the protective effects of two cannabinoids against acute paclitaxel toxicity. J Mol Neurosci 68:603\u2013619. 10.1007\/s12031-019-01321-z","journal-title":"J Mol Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s12031-022-02038-2","article-title":"Anti-inflammatory properties of KLS-13019: a novel GPR55 antagonist for dorsal root ganglion and hippocampal cultures","volume":"72","author":"Brenneman DE","year":"2022","unstructured":"Brenneman DE, Kinney WA, McDonnell ME, Zhao P, Abood ME, Ward SJ (2022) Anti-inflammatory properties of KLS-13019: a novel GPR55 antagonist for dorsal root ganglion and hippocampal cultures. J Mol Neurosci 72:1859\u20131874. 10.1007\/s12031-022-02038-2","journal-title":"J Mol Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12031-024-02217-3","article-title":"Knockdown of siRNA targeting GPR55 reveals significant differences between the anti-inflammatory actions of KLS-13019 and cannabidiol","volume":"74","author":"Brenneman DE","year":"2024","unstructured":"Brenneman DE, Kinney WA, McDonnell ME, Ippolito MJ, Ward SJ (2024) Knockdown of siRNA targeting GPR55 reveals significant differences between the anti-inflammatory actions of KLS-13019 and cannabidiol. J Mol Neurosci 74:41\u2013xx. 10.1007\/s12031-024-02217-3","journal-title":"J Mol Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"158891","DOI":"10.1016\/j.bbalip.2021.158891","article-title":"LPIAT1\/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol","volume":"1866","author":"Caddeo A","year":"2021","unstructured":"Caddeo A, Hedfalk K, Romeo S, Pingitore P (2021) LPIAT1\/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol. Biochim Biophys Act-Mol Cell Biol Lipids 1866:158891. 10.1016\/j.bbalip.2021.158891","journal-title":"Biochim Biophys Act-Mol Cell Biol Lipids"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3892\/mmr.2022.12671","article-title":"CID16020046, a GPR55 antagonist, attenuates sepsis-induced acute kidney injury","volume":"25","author":"Chen R","year":"2022","unstructured":"Chen R, Xu H, Guo Z, Zhang P, Chen J, Chen Z (2022) CID16020046, a GPR55 antagonist, attenuates sepsis-induced acute kidney injury. Mol Med Rep 25:152. 10.3892\/mmr.2022.12671","journal-title":"Mol Med Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1111\/bph.15486","article-title":"Behavioral and pharmacological effects of cannabidiol (CBD) and the CBD analogue KLS-13019 in mouse models of pain and reinforcement","volume":"178","author":"Foss JD","year":"2021","unstructured":"Foss JD, Farkas DJ, Huynh LM, Kinney WA, Brenneman DE, Ward SJ (2021) Behavioral and pharmacological effects of cannabidiol (CBD) and the CBD analogue KLS-13019 in mouse models of pain and reinforcement. Brit J Pharmacol 178:3067\u20133078. 10.1111\/bph.15486","journal-title":"Brit J Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.626687.eCollection","author":"Fumagalli G","year":"2021","unstructured":"Fumagalli G, Monza L, Cavaletti G, Rigolio R, Meregalli C (2021) Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy. Frontiers in Immunol 10.3389\/fimmu.2020.626687.eCollection 2020"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/gtc.12046","article-title":"Identification of small subunit of serine palmitoyltransferase a as a lysophophatidylinositol acyltransferase 1-interacting protein","volume":"18","author":"Hirata Y","year":"2024","unstructured":"Hirata Y, Yamamori N, Kono N, Hyeon-Cheol-Cheoi L, Inoue T, Arai H (2024) Identification of small subunit of serine palmitoyltransferase a as a lysophophatidylinositol acyltransferase 1-interacting protein. Genes Cells 18:397\u2013409. 10.1111\/gtc.12046","journal-title":"Genes Cells"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/molecules29061258","article-title":"Uncovering the power of GPR55 signaling: hosRvD2and other ligands have the potential to modulate and resolve inflammation in various health disorders","volume":"29","author":"Honkisz-Orzechowska E","year":"2024","unstructured":"Honkisz-Orzechowska E, Lazewskda D, Baran G, Kiec-Kononowicz K (2024) Uncovering the power of GPR55 signaling: hosRvD2and other ligands have the potential to modulate and resolve inflammation in various health disorders. Molecules 29:1258. 10.3390\/molecules29061258","journal-title":"Molecules"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404441","article-title":"Cellular succinate metabolism and signaling in inflammation: therapeutic intervention","author":"Huang H","year":"2024","unstructured":"Huang H, Li G, He Y, Chen J, Yan J, Zhang Q, Li L, Cai X (2024) Cellular succinate metabolism and signaling in inflammation: therapeutic intervention. Front Immunol. 10.3389\/fimmu.2024.1404441","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/hipo.22747","article-title":"A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity","volume":"27","author":"Hurst K","year":"2017","unstructured":"Hurst K, Badgley C, Ellsworth T, Bell S, Friend L, Prince B, Welch J, Cowan Z, Williamson R (2017) A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity. Hippocampus 27:985\u2013998. 10.1002\/hipo.22747","journal-title":"Hippocampus"},{"year":"2024","author":"Ippolito MJ","key":"ref17","unstructured":"Ippolito MJ, Kinney W, Brenneman DE, Ward SJ (2024) KLS-13019, a novel structural analogue of cannabidiol (CBD) and GPR55 antagonist, prevents and reverses chemotherapy-induced peripheral neuropathy (CIPN) in rats. J Pharmacol Exp Therap. In press"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.apha.2017.04.004","article-title":"Cannabinoid receptor-related orphan G protein-coupled receptors","volume":"80","author":"Irving A","year":"2017","unstructured":"Irving A, Abdulrazzaq G, Chan SLF, Penman J, Harvey J, Alexander SPH (2017) Cannabinoid receptor-related orphan G protein-coupled receptors. Adv Pharmacol 80:223\u2013247","journal-title":"Adv Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"doi: 10.1016\/bs.apha.2017.04.004","DOI":"10.1016\/bs.apha.2017.04.004"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/cjpp-2018-0741","article-title":"Molecular hydrogen suppresses free-radical-induced cell death by mitigating fatty acid peroxidation and mitochondrial dysfunction","volume":"10","author":"Iuchi K","year":"2019","unstructured":"Iuchi K, Nishimaki K, Kamimura N, Ohta S (2019) Molecular hydrogen suppresses free-radical-induced cell death by mitigating fatty acid peroxidation and mitochondrial dysfunction. Can J Physiol Pharmacol 10:999\u20131005","journal-title":"Can J Physiol Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0021-9258(20)82209-1","article-title":"The enzymatic acylation of lysophosphatidylinositol","volume":"239","author":"Keenan RW","year":"1964","unstructured":"Keenan RW, Hokin LE (1964) The enzymatic acylation of lysophosphatidylinositol. J Biol Chem 239:2123\u20132129","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1038\/s41598-022-12293-3","article-title":"Persistent elevation of lysophosphatidylcholine promotes radiation brain necrosis with microglial recruitment by P2RX4","volume":"12","author":"Kondo N","year":"2022","unstructured":"Kondo N, Sakurai Y, Takata T, Kano K, Kume K, Maeda M, Takai N, Suzuki S, Eto F et al (2022) Persistent elevation of lysophosphatidylcholine promotes radiation brain necrosis with microglial recruitment by P2RX4. Sci Rep 12:8718. doi.org\/10.1038\/s41598-022-12293-3","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"100151","DOI":"10.1016\/j.ynpai.2024.100151","article-title":"A review of dorsal root ganglion and primary sensory neuron plasticity mediating inflammatory and chronic neuropathic pain","volume":"15","author":"Jang K","year":"2024","unstructured":"Jang K, Garraway SM (2024) A review of dorsal root ganglion and primary sensory neuron plasticity mediating inflammatory and chronic neuropathic pain. Neurobiol Pain 15:100151","journal-title":"Neurobiol Pain"},{"key":"ref24","unstructured":"1016\/j.ynpai.2024.100151"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.10091\/mbc.E12-09-0673","article-title":"LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice","volume":"23","author":"Lee HC","year":"2021","unstructured":"Lee HC, Inoue T, Sasaki J, Kubo T, Matsuda S, Nakasaki Y, Hattore M et al (2021) LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice. Mol Biol Cell 23:4689. 10.10091\/mbc.E12-09-0673","journal-title":"Mol Biol Cell"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/acs.biochem.6b01013","article-title":"Identification of crucial amino acid residues involved in agonist signaling at the GPR55 receptor","volume":"56","author":"Lingerfelt MA","year":"2017","unstructured":"Lingerfelt MA, Zhao P, Sharir H, Hurst DP, Reggio PH, Abood ME (2017) Identification of crucial amino acid residues involved in agonist signaling at the GPR55 receptor. Biochemistry 56:473\u2013486. 10.1021\/acs.biochem.6b01013","journal-title":"Biochemistry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2174\/1570159X14666160729155441","article-title":"Advances in the physiology of GPR55 in the central nervous system","volume":"15","author":"Marichal-Cancino B","year":"2017","unstructured":"Marichal-Cancino B, Fajardo-Valdez AE, Ruiz-Contreras A, Mendez-Diaz M, Prospero-Garcia O (2017) Advances in the physiology of GPR55 in the central nervous system. Curr Neuropharm 15:771\u2013778. 10.2174\/1570159X14666160729155441","journal-title":"Curr Neuropharm"},{"year":"2023","author":"Martinez-Aguilar LM","key":"ref28","unstructured":"Martinez-Aguilar LM, Ibarra-Sanchez A, Guerrero-Morian DJ, Macias-Silva M, Munoz-Billo JO et al (2023) Lysophosphatidylinositol promotes chemotaxis and cytokine synthesis in mast cells with differential participation of GPR55 and CB2 receptors. I J Mol Sci 24:6316. doi.org\/103390\/ijms24076316"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.bbalip.2018.09.003","article-title":"Lysophosphatidylinositols in inflammation and macrophage activation: altered levels and anti-inflammation effects","volume":"1863","author":"Masquelier J","year":"2018","unstructured":"Masquelier J, Alhouayek M, Terrasi R, Bottemanne P, Paquot A, Muccioli G (2018) Lysophosphatidylinositols in inflammation and macrophage activation: altered levels and anti-inflammation effects. Biochim Biophys Acta Mol Cell Biol Lipids 1863:1458\u20131468","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"doi: 10.1016\/j.bbalip.2018.09.003","DOI":"10.1016\/j.bbalip.2018.09.003"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/biology12060805","article-title":"The expression of the endocannabinoid receptors CB2 and GPR55 is highly increased during the progression of Alzheimer\u2019s disease in APPNL\u2013G\u2013F knock-in mice","volume":"12","author":"Medina-Vera D","year":"2023","unstructured":"Medina-Vera D, Zhao H, Bereczki E, Rosell-Valle C, Shimozawa M, Chen G, Rodriguez de Fonseca F, Nilsson P, Tambaro S (2023) The expression of the endocannabinoid receptors CB2 and GPR55 is highly increased during the progression of Alzheimer\u2019s disease in APPNL\u2013G\u2013F knock-in mice. Biol 12:805. 10.3390\/biology12060805","journal-title":"Biol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s10753-020-01271-4","article-title":"Lysophosphatidylinositol, an endogenous ligand for G protein-coupled receptor 55, has anti-inflammatory effects in cultured microglia","volume":"43","author":"Minamihata T","year":"2020","unstructured":"Minamihata T, Takano K, Moriyama M, Nakamura Y (2020) Lysophosphatidylinositol, an endogenous ligand for G protein-coupled receptor 55, has anti-inflammatory effects in cultured microglia. Inflammation 43:1971\u20131987. 10.1007\/s10753-020-01271-4","journal-title":"Inflammation"},{"year":"2019","author":"Miranda AM","key":"ref33","unstructured":"Miranda AM, Bravo FV, Chan RB, Sousa N, Di Paolo G, Oliveira TG (2019) Differential lipid composition and regulation along the hippocampal longitudinal axis. Trans. Psych doi:.10.1038\/s41398-019-0478-6"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1084\/jem.20110367","article-title":"Mitochondrial reactive oxygen species drive proinflammatory cytokine production","volume":"208","author":"Naik E","year":"2011","unstructured":"Naik E, Dixit VM (2011) Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 208:417\u2013420. 10.1084\/jem.20110367","journal-title":"J Exp Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/brain\/awz063","article-title":"Electrophysiological and transcriptomic correlates of neuropathic pain in human dorsal root ganglion neurons","volume":"142","author":"North RY","year":"2019","unstructured":"North RY, Li Y, Ray P, Rhines LD, Tatsui CE, Rao G, Johansson CA, Zhang H, Kim YH et al (2019) Electrophysiological and transcriptomic correlates of neuropathic pain in human dorsal root ganglion neurons. Brain 142:1215\u20131226. 10.1093\/brain\/awz063","journal-title":"Brain"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvn136","article-title":"2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand of GPR55","volume":"145","author":"Oka S","year":"2009","unstructured":"Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (2009) 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand of GPR55. J Biochem 145:13\u201320","journal-title":"J Biochem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e24284","DOI":"10.1371\/journal.pone.0024284","article-title":"Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells","volume":"6","author":"Obara Y","year":"2011","unstructured":"Obara Y, Ueno S, Yanagihata Y, Nakahata N (2011) Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells. PLoS ONE 6:e24284","journal-title":"PLoS ONE"},{"key":"ref38","unstructured":"1371\/jornal.pone.0024284"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuroscience.2020.07.013","article-title":"Antinociceptive effects on the GPR55 antagonists CID16020046 injected into the rat anterior cingulate cortex","volume":"443","author":"Okine BN","year":"2020","unstructured":"Okine BN, Mc Laughlin G, Gaspar JC, Harhen B, Roche M, Finn DP (2020) Antinociceptive effects on the GPR55 antagonists CID16020046 injected into the rat anterior cingulate cortex. Neurosci 443:19\u201329. 10.1016\/j.neuroscience.2020.07.013","journal-title":"Neurosci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares M","year":"2020","unstructured":"Pajares M, Rojo A, Manda G, Bosco L, Cuadrado A (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9:1687. 10.3390\/cells9071687","journal-title":"Cells"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"105822","DOI":"10.1016\/j.phrs.2021.105822","article-title":"Pharmacological and structure-activity relationship studies of oleoyl-lysophosphatidylinositol synthetic mimetics","volume":"172","author":"Paternoster S","year":"2021","unstructured":"Paternoster S, Simpson PV, Kokh E, Kizilkaya HS, Rosenkilde MM, Mancera RL, Keating DJ, Massimiliano M, Falasca M (2021) Pharmacological and structure-activity relationship studies of oleoyl-lysophosphatidylinositol synthetic mimetics. Pharm Res 172:105822. doi.org\/10.1016\/j.phrs.2021.105822","journal-title":"Pharm Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.febslet.2009.05.028","article-title":"Differential changes in GPR55 during microglial cell activation","volume":"583","author":"Pietr M","year":"2009","unstructured":"Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, Vogel Z, Juknat A (2009) Differential changes in GPR55 during microglial cell activation. FEBS Lett 583:2071\u20132076. 10.1016\/j.febslet.2009.05.028","journal-title":"FEBS Lett"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1507\/endocrj. EJ16-0084","article-title":"Inverse agonism: the classic concept of GPCRs revisited","volume":"63","author":"Sato J","year":"2016","unstructured":"Sato J, Makit N, Iiri T (2016) Inverse agonism: the classic concept of GPCRs revisited. Endocr J 63:507\u2013514. 10.1507\/endocrj. EJ16-0084","journal-title":"Endocr J"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12974-018-1362-7","article-title":"Anti-neuroinflammatory effect of GPR55 antagonists in LPS-activated primary microglial cells","volume":"15","author":"Saliba SW","year":"2018","unstructured":"Saliba SW, Jauch H, Gargouri B, Keil A, Hurrle T, Volz N, Mohr F, van der Stelt M, Brase S, Fiebich BL (2018) Anti-neuroinflammatory effect of GPR55 antagonists in LPS-activated primary microglial cells. J Neuroinflam 15:322. doi.org\/10.1186\/s12974-018-1362-7","journal-title":"J Neuroinflam"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","article-title":"Pharmacological characterization of GPR55, a putative cannabinoid receptor","volume":"126","author":"Sharir H","year":"2010","unstructured":"Sharir H, Abood ME (2010) Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther 126:301\u2013313. 10.1016\/j.pharmthera.2010.02.004","journal-title":"Pharmacol Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/pain.2008.04.006","article-title":"The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain","volume":"139","author":"Staton PC","year":"2008","unstructured":"Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EN, Hughes JP, Chong E, Mander PK et al (2008) The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139:225\u2013236. 10.1016\/pain.2008.04.006","journal-title":"Pain"},{"issue":"38","key":"ref47","doi-asserted-by":"publisher","first-page":"E7997","DOI":"10.1073\/pnas.1705768114","article-title":"Dual role of mitochondria in producing melatonin and driving GPRC signaling to block cytochrome c release","volume":"114","author":"SuofuY, Li W","year":"2017","unstructured":"SuofuY, Li W, Jean-Alphonse FG, Jia J, Khattar NK, Li J et al (2017) Dual role of mitochondria in producing melatonin and driving GPRC signaling to block cytochrome c release. PNAS 114(38):E7997\u2013E8006. www.pnas.org\/cgi\/doi\/10.1073\/pnas.1705768114","journal-title":"PNAS"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","article-title":"Neuroinflammation and depression: a review","volume":"53","author":"Troubat R","year":"2021","unstructured":"Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, Brizard B, El Hage W, Surget A, Belzung C, Camus V (2021) Neuroinflammation and depression: a review. Eur J Neurosci 53:151\u2013171. 10.1111\/ejn.14720Epub 2020 Mar 20","journal-title":"Eur J Neurosci"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"872760","DOI":"10.3389\/fimmu,2022.872760","article-title":"TNF-a enhances sensory DRG neuron excitability through modulation of P2X3 receptors in an acute colitis model","volume":"13","author":"Valdez-Morales E","year":"2022","unstructured":"Valdez-Morales E, Sanchez-Navarro C, Reyes-Pavon D, Barrios-Garcia T, Ochoa-Cortes F, Barajas-Espinosa et al (2022) TNF-a enhances sensory DRG neuron excitability through modulation of P2X3 receptors in an acute colitis model. Front Immunol 13:872760. 10.3389\/fimmu,2022.872760. eCollection 2022","journal-title":"Front Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","article-title":"Neuronal plasticity: increasing the gain in pain","volume":"288","author":"Woolf CJ","year":"2000","unstructured":"Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765\u20131769. 10.1126\/science.288.5472.1765","journal-title":"Science"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"13328","DOI":"10.3390\/ijms222413328","article-title":"Gene expression data mining reveals the involvement of GPR55 and its endogenous ligands in immune response, cancer, and differentiation","volume":"22","author":"Wnorowski A","year":"2021","unstructured":"Wnorowski A, Wojcik J, Maj M (2021) Gene expression data mining reveals the involvement of GPR55 and its endogenous ligands in immune response, cancer, and differentiation. Intl J Mol Sci 22:13328. doi.org\/10.3390\/ijms222413328","journal-title":"Intl J Mol Sci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.prostaglandins.2013.05.004","article-title":"The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55","volume":"107","author":"Yamashita A","year":"2013","unstructured":"Yamashita A, Oka S, Tanikawa T, Hayashi Y, Nemoto-Sasaki Y, Suigiura T (2013) The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55. Prostaglandins other Lipid Mediators 107:103\u2013116. 10.1016\/j.prostaglandins.2013.05.004","journal-title":"Prostaglandins other Lipid Mediators"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00264","author":"Zhou J","year":"2016","unstructured":"Zhou J, Burkovskiy I, Yang H, Sardinha J, Lehmann C (2016) CB2 and GPP55 receptors as therapeutic targets for systemic immune dysregulation. Front Pharmacol. 7:264. oi:10.3389\/fphar.2016.00264 eCollection 2016"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5742954\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5742954\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:08:07Z","timestamp":1742227687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5742954\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":53,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5742954\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s12031-025-02326-7","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,1,8]]},"subtype":"preprint"}}